BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12878400)

  • 1. The influence of formulation variables on in vitro transfection efficiency and physicochemical properties of chitosan-based polyplexes.
    Romøren K; Pedersen S; Smistad G; Evensen Ø; Thu BJ
    Int J Pharm; 2003 Aug; 261(1-2):115-27. PubMed ID: 12878400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro gene delivery mediated by chitosan. effect of pH, serum, and molecular mass of chitosan on the transfection efficiency.
    Sato T; Ishii T; Okahata Y
    Biomaterials; 2001 Aug; 22(15):2075-80. PubMed ID: 11432586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between the physical shape and the efficiency of oligomeric chitosan as a gene delivery system in vitro and in vivo.
    Köping-Höggård M; Mel'nikova YS; Vårum KM; Lindman B; Artursson P
    J Gene Med; 2003 Feb; 5(2):130-41. PubMed ID: 12539151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and in vitro transfection efficiency of chitosan microspheres containing plasmid DNA:poly(L-lysine) complexes.
    Aral C; Akbuga J
    J Pharm Pharm Sci; 2003; 6(3):321-6. PubMed ID: 14738712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving transfection efficiency of ultrapure oligochitosan/DNA polyplexes by medium acidification.
    Agirre M; Zarate J; Puras G; Ojeda E; Pedraz JL
    Drug Deliv; 2015 Jan; 22(1):100-10. PubMed ID: 24471693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of an adenovirus vector plasmid by ultrapure oligochitosan based polyplexes.
    Agirre M; Zarate J; Ojeda E; Puras G; Rojas LA; Alemany R; Pedraz JL
    Int J Pharm; 2015 Feb; 479(2):312-9. PubMed ID: 25550211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low molecular weight linear polyethylenimine-b-poly(ethylene glycol)-b-polyethylenimine triblock copolymers: synthesis, characterization, and in vitro gene transfer properties.
    Zhong Z; Feijen J; Lok MC; Hennink WE; Christensen LV; Yockman JW; Kim YH; Kim SW
    Biomacromolecules; 2005; 6(6):3440-8. PubMed ID: 16283777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of Concentrated Chitosan/DNA Nanoparticle Formulations by Lyophilization for Gene Delivery at Clinically Relevant Dosages.
    Veilleux D; Nelea M; Biniecki K; Lavertu M; Buschmann MD
    J Pharm Sci; 2016 Jan; 105(1):88-96. PubMed ID: 26852843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-encapsulation of two plasmids in chitosan microspheres as a non-viral gene delivery vehicle.
    Ozbas-Turan S; Aral C; Kabasakal L; Keyer-Uysal M; Akbuga J
    J Pharm Pharm Sci; 2003; 6(1):27-32. PubMed ID: 12753728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation.
    Lavertu M; Méthot S; Tran-Khanh N; Buschmann MD
    Biomaterials; 2006 Sep; 27(27):4815-24. PubMed ID: 16725196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery.
    MacLaughlin FC; Mumper RJ; Wang J; Tagliaferri JM; Gill I; Hinchcliffe M; Rolland AP
    J Control Release; 1998 Dec; 56(1-3):259-72. PubMed ID: 9801449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable poly(2-dimethylamino ethylamino)phosphazene for in vivo gene delivery to tumor cells. Effect of polymer molecular weight.
    de Wolf HK; de Raad M; Snel C; van Steenbergen MJ; Fens MH; Storm G; Hennink WE
    Pharm Res; 2007 Aug; 24(8):1572-80. PubMed ID: 17435970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular design of chitosan gene delivery systems with an optimized balance between polyplex stability and polyplex unpacking.
    Strand SP; Lelu S; Reitan NK; de Lange Davies C; Artursson P; Vårum KM
    Biomaterials; 2010 Feb; 31(5):975-87. PubMed ID: 19857892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier.
    Kim TH; Park IK; Nah JW; Choi YJ; Cho CS
    Biomaterials; 2004 Aug; 25(17):3783-92. PubMed ID: 15020154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan nanoparticles for plasmid DNA delivery: effect of chitosan molecular structure on formulation and release characteristics.
    Bozkir A; Saka OM
    Drug Deliv; 2004; 11(2):107-12. PubMed ID: 15200009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting.
    Gao S; Chen J; Xu X; Ding Z; Yang YH; Hua Z; Zhang J
    Int J Pharm; 2003 Apr; 255(1-2):57-68. PubMed ID: 12672602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency.
    Mao HQ; Roy K; Troung-Le VL; Janes KA; Lin KY; Wang Y; August JT; Leong KW
    J Control Release; 2001 Feb; 70(3):399-421. PubMed ID: 11182210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyelectrolyte complexes and layer-by-layer capsules from chitosan/chitosan sulfate.
    Berth G; Voigt A; Dautzenberg H; Donath E; Möhwald H
    Biomacromolecules; 2002; 3(3):579-90. PubMed ID: 12005531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of chitosan structure on the formation and stability of DNA-chitosan polyelectrolyte complexes.
    Strand SP; Danielsen S; Christensen BE; Vårum KM
    Biomacromolecules; 2005; 6(6):3357-66. PubMed ID: 16283766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between the degree of acetylation and the electrostatic properties of chitin and chitosan.
    Sorlier P; Denuzière A; Viton C; Domard A
    Biomacromolecules; 2001; 2(3):765-72. PubMed ID: 11710030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.